Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$67,348,183
+$56,521,657 QoQ
Shares Held
483,233
+447.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.28336847856004.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7166315214399679.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $2,302,649,106 across 19 Drug Manufacturers - General names. GILD ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
650,867 | $598,647,939 | |
| 2 | JNJ |
Johnson & Johnson
|
1,551,388 | $379,221,282 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,659,381 | $319,896,940 | |
| 4 | NVS |
Novartis AG
|
1,821,796 | $278,279,339 | |
| 5 | AZN |
Astrazeneca PLC
|
1,004,416 | $198,090,923 | |
| 6 | ABBV |
AbbVie Inc.
|
777,405 | $169,077,812 | |
| 7 | PFE |
Pfizer Inc
|
4,521,343 | $126,959,311 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
483,233 | $67,348,183 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,348,183 | 483,233 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,826,526 | 88,207 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,858,133 | 79,803 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,055,702 | 72,659 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,141,282 | 63,733 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $4,785,134 | 51,804 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,063,596 | 36,541 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,451,238 | 21,152 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $440,891 | 6,019 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $117,220 | 1,447 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $69,544 | 928 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $71,520 | 928 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $86,371 | 1,041 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $60,953 | 710 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,728 | 644 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $39,805 | 644 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $38,285 | 644 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $74,425 | 1,025 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $71,596 | 1,025 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $73,611 | 1,069 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $143,026 | 2,213 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $77,311 | 1,327 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||